Question 1

What are the main uses of metformin?

Accepted Answer

Metformin is a prescribed medication used to manage diabetes (type 2) by improving insulin sensitivity and reducing glucose production in the liver. It is also prescribed for gestational diabetes in some cases and can help prevent the onset of type 2 diabetes in people at very high risk. Additionally, metformin is sometimes used off-label for conditions like polycystic ovary syndrome (PCOS) due to its ability to lower insulin resistance. Its effectiveness, combined with a low risk of hypoglycemia, makes it a first-line treatment for diabetes management.

Question 2

Should rosiglitazone be taken before or after food?

Accepted Answer

Rosiglitazone can be taken with or without a meal, as food intake does not majorly affect its absorption or efficacy. The medication is generally administered once or twice daily, depending on the prescribed dosage. Patients should follow their doctor's instructions regarding timing, but do not need to adjust their meals around taking rosiglitazone.

Question 3

What are metformin and rosiglitazone used for?

Accepted Answer

The combination of metformin and rosiglitazone is used to treat or manage type 2 diabetes when diet, exercise, or monotherapy alone are insufficient for blood sugar control. Metformin works by decreasing liver glucose production and improving insulin sensitivity, while rosiglitazone enhances insulin action in muscle and fat tissues. Together, they provide a more comprehensive approach to managing diabetes, though they require careful monitoring due to possible side effects, such as fluid retention or gastrointestinal issues.

Question 4

What are the contraindications for rosiglitazone?

Accepted Answer

Rosiglitazone is contraindicated in patients with severe heart failure (NYHA Class III or IV), active or history of diabetic ketoacidosis, type 1 diabetes, or acute heart conditions like myocardial infarction or severe angina. It should also be avoided in patients with liver impairment or hypersensitivity to the drug. Due to its association with fluid retention and worsening heart failure, rosiglitazone requires cautious use in individuals with cardiovascular risk factors.

Question 5

Is rosiglitazone contraindicated in heart failure?

Accepted Answer

Yes, rosiglitazone is contraindicated in patients with established NYHA Class III or IV heart failure due to its potential to cause or worsen fluid retention and cardiac complications. Even in milder cases of symptomatic heart failure, its use is generally discouraged. The drug’s mechanism of action can increase plasma volume, leading to decompensation in vulnerable patients, making careful cardiovascular assessment essential before prescribing.

Question 6

What is the half-life of rosiglitazone?

Accepted Answer

The elimination half-life of rosiglitazone is approximately 3 to 4 hours, but its active metabolites have a significantly longer half-life, contributing to its prolonged therapeutic effects. Despite the parent drug's relatively short half-life, its metabolites could remain in the body for extended periods, which is why rosiglitazone is effective with once- or twice-daily dosing. This pharmacokinetic profile helps maintain steady blood glucose control throughout the day.

Avandamet

Similar Medications